Takeda Pharmaceutical (TAK) Enterprise Value: 2018-2025

  • Takeda Pharmaceutical's Enterprise Value rose 10.13% to $44.5 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $29.6 billion, marking a year-over-year increase of 54.02%. This contributed to the annual value of $44.5 billion for FY2025, which is 10.36% up from last year.
  • As of Q1 2025, Takeda Pharmaceutical's Enterprise Value stood at $44.5 billion, which was up 10.13% from $40.4 billion recorded in Q1 2024.
  • Takeda Pharmaceutical's Enterprise Value's 5-year high stood at $47.4 billion during Q1 2021, with a 5-year trough of $37.2 billion in Q1 2022.
  • Over the past 3 years, Takeda Pharmaceutical's median Enterprise Value value was $44.5 billion (recorded in 2025), while the average stood at $43.9 billion.
  • Per our database at Business Quant, Takeda Pharmaceutical's Enterprise Value declined by 21.45% in 2022 and then rose by 25.96% in 2023.
  • Over the past 5 years, Takeda Pharmaceutical's Enterprise Value (Quarterly) stood at $47.4 billion in 2021, then declined by 21.45% to $37.2 billion in 2022, then rose by 25.96% to $46.9 billion in 2023, then dropped by 13.90% to $40.4 billion in 2024, then rose by 10.13% to $44.5 billion in 2025.
  • Its last three reported values are $44.5 billion in Q1 2025, $40.4 billion for Q1 2024, and $46.9 billion during Q1 2023.